Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 7:51 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 241–264 of 396 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Foot Ulcers, Diabetic Clear all

Conditions: Diabetic Foot Ulcer
Interventions: Dual-layer perinatal tissue allograft, Three-layer fenestrated perinatal tissue allograft, Standard of care; Other
Lead sponsor: Samaritan Biologics; Industry
Eligibility: 18 Years and older
Enrollment: 170 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Monroe, North Carolina

Conditions: Diabetic Foot Ulcer, Wound Healing, Wound Care
Interventions: Not listed
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Diabetic Foot Ulcers
Interventions: diffuse near infrared spectroscopy measurements; Device
Lead sponsor: Drexel University College of Medicine; Other
Eligibility: 18 Years to 65 Years
Enrollment: 38 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2014
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Diabetic Foot Ulcer
Interventions: Amnion-Intermediate-Chorion, Standard of Care (SOC); Other · Procedure
Lead sponsor: Cellution Biologics; Industry
Eligibility: 18 Years and older
Enrollment: 84 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 8
States / cities: Santa Rosa, California • Jacksonville, Florida • Chicago, Illinois + 5 more

Conditions: Wounds, Leg Ulcers, Pressure Ulcers, Diabetic Foot Ulcers
Interventions: AutoloGel System; Device
Lead sponsor: Cytomedix; Industry
Eligibility: 18 Years to 95 Years
Enrollment: 131 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2012
U.S. locations: 2
States / cities: Augusta, Georgia • El Paso, Texas

Conditions: Diabetes Complications, Diabetes, Diabetic Foot Ulcer, Wound Infection
Interventions: Telcare 2.0 BGM; Device
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years and older
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Diabetic; Foot Ulcers
Interventions: Offloading, Dressing Application; Other
Lead sponsor: Musculoskeletal Transplant Foundation; Other
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2017
U.S. locations: 3
States / cities: Roanoke, Virginia • Salem, Virginia

Conditions: Diabetic Foot Ulcer
Interventions: Bioresorbable 3D electrospun synthetic matrix; Device
Lead sponsor: RenovoDerm; Industry
Eligibility: 18 Years and older
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025
U.S. locations: 1
States / cities: Northampton, Pennsylvania

Conditions: Diabetic Foot Ulcer
Interventions: Standard of Care, Nitric Oxide Therapy 2x week 6 min. plus standard of care, Nitric Oxide Therapy 2x week 12 min. plus standard of care, Nitric Oxide Therapy 4x week 6 min. plus standard of care, Nitric Oxide Therapy 4x week 12 min. plus standard of care; Device
Lead sponsor: Origin Inc.; Industry
Eligibility: 22 Years to 85 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 15
States / cities: Montgomery, Alabama • Phoenix, Arizona • Tucson, Arizona + 11 more

Conditions: Diabetic Foot Ulcers (DFUs)
Interventions: Bonvadis® (NWBOT), Clostridial Collagenase Ointment; Device
Lead sponsor: Oneness Biotech Co., Ltd.; Industry
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 10
States / cities: North Port, Florida • Palm Coast, Florida • South Miami, Florida + 7 more

Conditions: Diabetic Foot, Diabetic Foot Ulcer, Foot Ulcer, Chronic Foot Ulcer
Interventions: Symphony™ plus Off-loading, Wound Dressing comprising of calcium alginate Fibracol; Device
Lead sponsor: Aroa Biosurgery Limited; Industry
Eligibility: 18 Years and older
Enrollment: 143 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 11
States / cities: Los Angeles, California • San Francisco, California • Miami, Florida + 7 more

Conditions: Diabetic Foot Ulcer, Venous Ulcer
Interventions: Low Frequency, Low Intensity Ultrasound, Sham Applicator; Device
Lead sponsor: Drexel University; Other
Eligibility: 18 Years and older
Enrollment: 72 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2023
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Diabetic Foot Ulcers, Pressure Ulcers
Interventions: HP828-101, Hydrogel/Hydrocolloid; Device
Lead sponsor: Healthpoint; Industry
Eligibility: 18 Years and older
Enrollment: 88 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 11
States / cities: Bakersfield, California • Chula Vista, California • Fresno, California + 7 more

Conditions: Ulcer Healing, Diabetic Foot Ulcer
Interventions: human keratin graft; Device
Lead sponsor: ProgenaCare Global, LLC; Industry
Eligibility: 18 Years and older
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023
U.S. locations: 3
States / cities: Miami, Florida • Frederick, Maryland • Salem, Virginia

Conditions: Lower Extremity Chronic Ulcers in Diabetics, Diabetic Foot Ulcer (DFU)
Interventions: amniotic membrane; Other
Lead sponsor: Tides Medical; Industry
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023
U.S. locations: 5
States / cities: North Port, Florida • Buffalo, New York • Monroeville, Pennsylvania + 2 more

Conditions: Chronic Ulcers, Diabetic Foot Ulcers (DFU), DFU, Ulcer
Interventions: Corplex P is used to cover, protect, and provide a moist wound environment; Device
Lead sponsor: StimLabs; Industry
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: Bridgeport, Connecticut

Conditions: Diabetic Foot Ulcer
Interventions: Not listed
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years and older
Enrollment: 142 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 5
States / cities: Palo Alto, California • San Francisco, California • Miami, Florida + 2 more

Conditions: Chronic Wounds With Different Etiologies
Interventions: Swabs; Other
Lead sponsor: Systagenix Wound Management; Industry
Eligibility: 18 Years and older
Enrollment: 135 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012
U.S. locations: 1
States / cities: Tulsa, Oklahoma

Conditions: Diabetic Foot Ulcer
Interventions: 0.03% DSC127 topical gel; Drug
Lead sponsor: Integra LifeSciences Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 261 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015
U.S. locations: 21
States / cities: Mobile, Alabama • Chino, California • Fresno, California + 16 more

Conditions: Diabetic Foot, Ulcer Foot
Interventions: no interventions; Other
Lead sponsor: Indiana University; Other
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Diabetic Foot Ulcer, Pressure Injury, Pressure Ulcer
Interventions: Invia Motion Endure; Device
Lead sponsor: Medela AG; Industry
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Augusta, Georgia

Conditions: Diabetic Foot Ulcer
Interventions: dermaPACE; Device
Lead sponsor: SANUWAVE, Inc.; Industry
Eligibility: 22 Years and older
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Newark, New Jersey

Conditions: Diabetic Foot Ulcer
Interventions: ALLO-ASC-SHEET; Biological
Lead sponsor: Anterogen Co., Ltd.; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 64 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Diabetic Foot Ulcer, Type 2 Diabetes
Interventions: Specimen Collection; Other
Lead sponsor: Winthrop University Hospital; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2020
U.S. locations: 1
States / cities: Mineola, New York

Search by objective public record fields.

Evaluating the Efficacy of Perinatal Membrane Allografts in Addition to the Standard of Care for the Treatment of Non-healing Diabetic Foot Ulcers.

Tele-Exercise Platform for Plantar Wound Healing

Non-Invasive Assessment of Wound Healing With Optical Methods

Nonhealing Diabetic Foot Ulcers Treated With Standard of Care (SOC) Alone or Standard of Care and Amnion-Intermediate-Chorion (AIC)

The AutoloGel™ Post-Market Surveillance (TAPS) Program

Diabetic Foot Ulcer and Wound Infection

Allogenic Dermis Versus Standard Care in the Management of Diabetic Foot Ulcers

Pilot Study of PHOENIX Wound Matrix® Impact on Chronic DFU Wound Microbiome

A Feasibility Study of Advance Plasma Therapy001 Plasma/Nitric Oxide Therapy for the Treatment of Diabetic Foot Ulcers

PREPUP: A Randomized Trial of Bonvadis® Versus Collagenase Ointment in Diabetic Foot Ulcers

Clinical Study Evaluating Symphony™ Versus Standard of Care in the Treatment of Non-Healing Diabetic Foot Ulcers

Enhanced Ultrasound Treatment of Chronic Wounds With Monitoring of Healing and Quality of Life Outcomes

Evaluation of the Effects of HP828-101 Versus Standard of Care in the Management of Partial or Full Thickness Wounds

Evaluating The Efficacy Of A Keratin Graft In Treating Non-Healing Diabetic Foot Ulcers

Artacent Amniotic Tissue for Treatment of Chronic Lower Extremity Diabetic Ulcers.

Case Series of StimLabs Dehydrated Human Umbilical Cord Particulate for Acute and Chronic Wounds

Adjunct Collection of Additional Biorepository Data From Patients Enrolled in Diabetic Foot Consortium (DFC) Trials

Swab Sample Collection for the Detection of Bacterial Proteases in Wounds Assay

Open-Label Study in Diabetic Foot Ulcers (DFU), to Evaluate Safety of 0.03% DSC127 Topical Gel in Chronic Use

Diabetic Foot Ulcer Recurrence: Pilot Study

Evaluating Clinical Acceptance of a NPWT Wound Care System

The Effects of High Energy Acoustic Shock Wave Therapy on Local Skin Perfusion and DFUs

Clinical Study of ALLO-ASC-SHEET in Subjects With Diabetic Wagner Grade II Foot Ulcers

Development of a Cellular Biomarker for the Diagnosis and Treatment of Diabetic Foot Ulcers